Autor/es reacciones Xavier Morató Director of Clinical Trials at Ace Alzheimer Center Barcelona Ace Alzheimer Center Barcelona Reaction: study shows Alzheimer's drug lecanemab helps neutralise the effects of small toxic amyloid aggregates Language EN